Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2025-12-26 @ 12:18 PM
Study NCT ID:
NCT06654700
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-20
First Post:
2024-10-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
Sponsor:
MAXVAX Biotechnology Limited Liability Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-22
First Submit QC Date:
None
Study First Post Date:
2024-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-18
Last Update Post Date:
2024-11-20
Last Update Post Date Type:
ACTUAL